Azithromycin tab 250 mg: Discontinuation

Discontinuation Active

We are discontinuing the supply of azithromycin 250 mg tablets from 1 May 2022. The 500 mg strength of azithromycin will remain available

Why are we doing this?

Apotex is discontinuing the supply of azithromycin 250 mg tablets. We have secured an alternative brand of the 500 mg strength of azithromycin, which will remain available.

Latest updates on Apotex products

Key dates

October 2021: stock exhausted

We anticipate that stocks of azithromycin 250 mg tablets will be exhausted in October 2021.  

1 May 2022: tablets delisted

The May 2022 delisting date allows for dispensing of residual stock within the supply chain. 

Alternative product 

We have secured supply of the Zithromax brand of azithromycin 500 mg tablets. The new brand has a score line to allow the tablet to be split easily. 

Read more detail about the ongoing supply of azithromycin tab 500 mg 

Who to contact

If you have any questions, email enquiry@pharmac.govt.nz